In Vitro Activity of Benzimidazole (SPR719) Against Clinical Isolates of Nontuberculous Mycobacteria With and Without Clarithromycin or Amikacin Resistance

Limited data are available regarding the in vitro activity of SPR719, a derivative of benzimidazole, against diverse nontuberculous mycobacteria (NTM) species. We investigated the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of SPR719 against clinical NTM isola...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dae Hun, Zo, Sungmin, Kim, Su-Young, Jhun, Byung Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Laboratory Medicine 2024
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485866/
https://www.ncbi.nlm.nih.gov/pubmed/37665290
http://dx.doi.org/10.3343/alm.2024.44.1.92

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485866/
https://www.ncbi.nlm.nih.gov/pubmed/37665290
http://dx.doi.org/10.3343/alm.2024.44.1.92

Ejemplares similares